Literature DB >> 15814238

Alginate rafts and their characterisation.

F C Hampson1, A Farndale, V Strugala, J Sykes, I G Jolliffe, P W Dettmar.   

Abstract

Alginate/antacid anti-reflux preparations are designed to provide symptom relief by forming a physical barrier on top of the stomach contents in the form of a neutral floating gel or raft. This study tested the in vitro effectiveness of a range of liquid products in forming rafts that were cohesive, buoyant, voluminous, resistant to reflux and durable under conditions of movement (resilient). The products tested had a wide range of acid neutralising capacities (ANCs). It was found that products with a high ANC and no calcium ion source formed rafts of low strength, weight and volume, which appeared more as floating precipitates than coherent gels. Products with a high ANC and a calcium ion source formed medium strength, weight and volume rafts. Products with a low ANC formed strong coherent rafts with medium to large weight and volume, and those with low ANC and a calcium ion source formed the strongest rafts. Products with stronger rafts were found to be more resilient and more resistant to reflux in an in vitro reflux model. Significant overall differences in raft buoyancy were found between products forming coherent rafts but these could not be related to the product formulation or amount of available carbon dioxide.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814238     DOI: 10.1016/j.ijpharm.2005.01.036

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  15 in total

1.  A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms.

Authors:  Edoardo G Giannini; Patrizia Zentilin; Pietro Dulbecco; Elena Iiritano; Claudio Bilardi; Edoardo Savarino; Carlo Mansi; Vincenzo Savarino
Journal:  Dig Dis Sci       Date:  2006-09-15       Impact factor: 3.199

2.  Alginates: From the ocean to gastroesophageal reflux disease treatment.

Authors:  Serhat Bor; İsmail Hakkı Kalkan; Altay Çelebi; Dinç Dinçer; Filiz Akyüz; Peter Dettmar; Hasan Özen
Journal:  Turk J Gastroenterol       Date:  2019-09       Impact factor: 1.852

3.  Gaviscon Double Action Liquid (antacid & alginate) is more effective than antacid in controlling post-prandial oesophageal acid exposure in GERD patients: a double-blind crossover study.

Authors:  A De Ruigh; S Roman; J Chen; J E Pandolfino; P J Kahrilas
Journal:  Aliment Pharmacol Ther       Date:  2014-07-10       Impact factor: 8.171

Review 4.  Medical Treatment of Gastroesophageal Reflux Disease.

Authors:  Daniel A Kroch; Ryan D Madanick
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

Review 5.  Foundations of gastrointestinal-based drug delivery and future developments.

Authors:  Jacqueline N Chu; Giovanni Traverso
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-11-16       Impact factor: 46.802

6.  Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial.

Authors:  Denis Pouchain; Marc-André Bigard; François Liard; Marc Childs; Annick Decaudin; Donna McVey
Journal:  BMC Gastroenterol       Date:  2012-02-23       Impact factor: 3.067

7.  Alginate-Iron Speciation and Its Effect on In Vitro Cellular Iron Metabolism.

Authors:  Richard D Horniblow; Miriam Dowle; Tariq H Iqbal; Gladys O Latunde-Dada; Richard E Palmer; Zoe Pikramenou; Chris Tselepis
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

8.  Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy.

Authors:  Vicki Strugala; Julian Bassin; Valerie S Swales; Stephen W Lindow; Peter W Dettmar; Edward C M Thomas
Journal:  ISRN Obstet Gynecol       Date:  2012-11-04

9.  Formulation and optimisation of raft-forming chewable tablets containing H2 antagonist.

Authors:  Shailesh T Prajapati; Anant P Mehta; Ishan P Modhia; Chhagan N Patel
Journal:  Int J Pharm Investig       Date:  2012-10

10.  Evaluation of an Innovative Over-the-Counter Treatment for Symptoms of Reflux Disease: Quick-Dissolving Alginate Granules.

Authors:  Vicki Strugala; Peter W Dettmar; Edward C M Thomas
Journal:  ISRN Pharm       Date:  2012-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.